Using a wearable vest to measure lung fluid in heart failure patients
Official title: Remote Dielectric Sensing Technology Guided Diuresis in Hospitalized Patients With Acute Decompensated Heart Failure
Run by University of California, San Francisco · NCT03586336 · Data updated 2026-11-12
This study is testing a new wearable vest that measures lung fluid in heart failure patients to see if it can help them get better treatment compared to standard care.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years and up |
| Sex | All |
| Enrollment | 100 (estimated) |
| Sponsor | University of California, San Francisco Academic / other |
| Locations | 1 site (San Francisco, California) |
| Status | Recruiting |
| Started | December 1, 2018 |
| Main results expected | December 31, 2027 |
| Study ends | December 31, 2027 |
| Registry record updated | September 2, 2026 |
| Trial ID | NCT03586336 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are hospitalized adults with acute decompensated heart failure who require intravenous diuretics or vasoactive drugs.
✕Probably not a fit
Patients with chronic renal failure, significant lung issues, or those requiring inotropic support may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study evaluates the effectiveness of a wearable vest that non-invasively measures lung fluid content in hospitalized patients suffering from acute decompensated heart failure. The approach involves using Remote Dielectric Sensing (ReDS) technology to guide diuresis treatment, which is traditionally managed through less reliable clinical methods. Patients will be randomly assigned to either receive ReDS-guided treatment or usual care, with daily measurements taken for all participants. The goal is to determine if ReDS can improve patient outcomes by providing more accurate assessments of fluid status.
Why it matters
Potential benefit: If successful, this approach could lead to more effective management of fluid overload in heart failure patients, potentially reducing hospital stays and improving recovery times.
How similar studies have gone: Other studies utilizing non-invasive monitoring technologies have shown promise, suggesting that this approach could be beneficial, though the specific use of ReDS in this context is relatively novel.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Patients hospitalized for acute decompensated heart failure requiring treatment with intravenous diuretics and/or IV vasoactive drugs * Patient has signed informed consent and has authorized use and disclosed health information * Patient is at least 18 years of age * Patient physically suitable for ReDS measurement * GFR\>25 * Initial ReDS Measurement \>35% Exclusion Criteria: * Patient characteristics excluded from approved use of ReDS system: height less than 155cm or greater than 190cm, BMI \<22 or \>39, chest circumference \<80cm or \>115cm , or flail chest * Evidence of focal lung lesions on history, physical exam or chest x-ray, including history of pulmonary embolism, active pneumonia, or known lung nodule * Chronic renal failure (GFR\<25) * Prior cardiac surgery within 2 months of index admission * Patient has a ventricular assist device or has had a cardiac transplantation * Patients in cardiogenic shock at admission requiring inotropic support * Congenital heart malformations or intra-thoracic mass that would affect right-lung anatomy (e.g dextrocardia, lung carcinoma, or pacemaker box in the right chest)
Where it's running
-
University of California, San Francisco
San Francisco, California, United States Recruiting
Study contacts
- Principal investigator: Liviu Klein, MD, MS — Director, Mechanical Circulatory Support and Heart Failure Device Program
- Study coordinator: Cynthia Partida-Higuera
- Email: Cynthia.Partida-Higuera@ucsf.edu
- Phone: 415-514-1125
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Using Apple Watch data to predict heart failure outcomes
This study is testing if data from Apple Watches can help predict heart failure problems and the chances of needing to go back to the hospital for patients with heart failure.
-
Comparing Aortix Device to Diuretics for Acute Heart Failure
This study is testing whether the Aortix device can help people with acute heart failure who aren't responding to diuretics feel better compared to standard treatment.
-
Using intravenous albumin to prevent worsening kidney function in heart failure patients
This study is testing if giving heart failure patients a special protein through an IV can help their kidneys work better when they're also having liver problems.
-
Using biomarkers to guide the discharge of heart failure patients from the hospital
This study is testing if using specific blood tests can help doctors decide when it's safe to send heart failure patients home from the hospital, compared to standard care.
-
Myocardial Energetics Across Cardiovascular Disease Spectrum Using 31P-MRS
Researchers are testing whether phosphorus-31 magnetic resonance spectroscopy (31P-MRS) can map heart energy metabolism across healthy people and patients with various heart conditions.
-
Tailored digital support to cut sedentary time in long-term cardiac rehab
In adults in a long-term cardiac rehabilitation program, this study tests whether a personalized behavioural program with digital tools can reduce daily sitting time.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.